Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Seaport Therapeutics, Inc. (SPTX)

$21.10 -3.83% NASDAQ: SPTX · 15-min delayed
  • BOSTON, Massachusetts
  • Public · NASDAQ: SPTX
$1.1BMarket cap
SPTXNASDAQ
2026IPO

About Seaport Therapeutics, Inc.

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Market cap
$1.1B
NASDAQ: SPTX
$21.10 -3.83%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$15.25 $22.52

52-week range

Market cap
$1.1B
Shares outstanding
41.3M
Open
Day range
Prev close
Volume
IPO date
May 1, 2026

Seaport Therapeutics, Inc. (SPTX) Stock Price

  • Trading 6% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Seaport Therapeutics, Inc..

Write a review
FAQ

Seaport Therapeutics, Inc.: frequently asked questions

Is Seaport Therapeutics, Inc. an American company?

Seaport Therapeutics, Inc. is a US-based company headquartered in Boston, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Seaport Therapeutics, Inc. headquartered?

Seaport Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.

Is Seaport Therapeutics, Inc. publicly traded?

Yes — Seaport Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol SPTX on the NASDAQ.

What does Seaport Therapeutics, Inc. do?

Seaport Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →